CIDEC and hypertriglyceridemia: In conclusion, this study has indicated that 3′ UTR variation in CIDEC is associated with the risk of elevated fasting glucose, the progression of hypertriglyceridemia and hypertension, and the efficacy of angiotensin II-targeted antihypertensive agents.